arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Milestone Pharmaceuticals Inc.

MIST Health Care Biotechnology: Pharmaceutical Preparations
$0.65
▼ -6.7% Today
as of Oct 23, 16:19 ET
Last 30 days -31.70% Sep 14 → Oct 23
$0.62 $0.71 $0.80 $0.89 $0.97 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.69
High
$0.73
Low
$0.69
Volume
$621,331
Avg Vol
$3M
Mkt Cap
$102M
P/E (TTM)
—
Beta
—
52w High
$3.06
52w Low
$0.69
Div Yield
—
Shares Out
$124M

Recent Press Releases & News last 60 days · 8 items

Oct 23 · 08:13 Simply Wall St.
Milestone Pharmaceuticals (MIST) Stock Sees Fair Value Falls As Analysts Reset Cardamyst Expectations
Oct 19 · 12:00 PR GlobeNewswire
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
Oct 9 · 12:43 MT Newswires
Milestone Pharmaceuticals Enrolls First EU Patient in Phase 3 Etripamil Trial in Atrial Fibrillation
▸ Show all 8 press releases & news Free account →

MIST earnings at a glance

The options market is pricing a move of about ±21.7% after the report, a range of roughly $0.51 to $0.79 from today's $0.65. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±5.6% on average; after the most recent report on May 13, 2026 it moved -9.5%. That means options currently expect more movement than MIST has typically delivered. MIST beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 106%. The share price of $0.65 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.69
$3.06
0% of range
Avg surprise (last 4)
-152.9%
Avg reaction (last 2)
-5.6%
0% positive
Latest IV / EM
106%
EM ±21.7% · $1 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.37$-0.29$-0.20$-0.11$-0.03 Actual $-0.35Actual $-0.37Actual $-0.35Actual $-0.21Actual $-0.14Actual $-0.14Actual $-0.31Est $-0.19Actual $-0.20Est $-0.18Actual $-0.12Est $-0.17Actual $-0.20Est $-0.03Actual $-0.21 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-29M$-21M$-14M$-7M$586,950 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.21 — — — — financials
Wed May 13, 2026Mar/2026 $-0.20 $-0.03 -566.7% +35.5% -9.5% earnings
Wed Nov 12, 2025Sep/2025 $-0.12 $-0.17 +29.4% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.20 $-0.18 -11.1% — — earnings
Wed May 14, 2025Mar/2025 $-0.31 $-0.19 -63.2% — -1.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.14 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.14 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.21 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.35 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.37 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.35 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$559,000$238,000——$0$0——
Cost of revenue$32,000$14,000——$0$0——
Gross profit————————
Operating income$-26M$-24M—$-12M$-13M$-21M—$-10M
Net income$-29M$-26M—$-12M$-13M$-21M—$-9M
EPS (diluted)$-0.21$-0.20—$-0.12$-0.20$-0.31—$-0.14

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$170M$71M$73M$47M$42M$45M$25M$13M
Inventory$5M$2M$648,000—————
Total current assets$180M$192M$112M$87M$46M$60M$74M$81M
Total assets$182M$194M$114M$88M$47M$62M$75M$83M
Long-term debt$59M$58M$57M$56M$55M$54M$53M$52M
Total liabilities$163M$158M$72M$67M$65M$68M$62M$59M
Total equity$18M$36M$42M$21M$-18M$-6M$13M$24M

Implied volatility — last 90 days

54%195%335%475%615% Jun 07 — IV 352% · EM ±48.8%Jun 09 — IV 597% · EM ±74.8%Jun 11 — IV 356% · EM ±39.4%Jun 12 — IV 616% · EM ±63.0%Jun 19 — IV 70% · EM ±15.4%Jun 22 — IV 55% · EM ±11.4%Jun 23 — IV 56% · EM ±11.4%Jun 29 — IV 64% · EM ±11.3%Jun 30 — IV 65% · EM ±11.2%Jul 01 — IV 69% · EM ±11.4%Jul 02 — IV 68% · EM ±11.0%Jul 03 — IV 73% · EM ±11.4%Jul 06 — IV 82% · EM ±11.4%Jul 22 — IV 496% · EM ±113.4%Jul 23 — IV 519% · EM ±116.7%Jul 24 — IV 410% · EM ±90.5%Jul 27 — IV 572% · EM ±119.5%Jul 28 — IV 183% · EM ±37.4%Aug 24 — IV 115% · EM ±24.0%Aug 25 — IV 358% · EM ±73.3%Aug 26 — IV 381% · EM ±76.3%Aug 27 — IV 169% · EM ±33.1%Aug 28 — IV 225% · EM ±43.1%Aug 31 — IV 341% · EM ±60.3%Sep 01 — IV 280% · EM ±48.2%Sep 02 — IV 533% · EM ±89.0%Sep 03 — IV 281% · EM ±45.5%Sep 04 — IV 288% · EM ±44.9%Sep 14 — IV 252% · EM ±21.1%Sep 21 — IV 104% · EM ±21.8%Sep 22 — IV 106% · EM ±21.7%

Sector peers

ZSTK
ZeroStack Corp.
$104M $3.18-10.9%
OKUR
OnKure Therapeutics, Inc.
$95M $2.52+9.6%
RLYB
Rallybio Corporation
$90M $16.64+2.6%
GNLX
Genelux Corporation
$114M $2.00-3.4%
LIXT
Lixte Biotechnology Holdings, Inc.
$115M $7.21+75.8%
AARD
Aardvark Therapeutics, Inc.
$115M $1.39-68.5%

MIST earnings FAQ

What is MIST's expected move for earnings?

Options currently price a move of about ±21.7%, or $0.14 per share either way from $0.65.

How does MIST stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.6%, up 0 times and down 2 times.

What is MIST's implied volatility?

MIST's at-the-money implied volatility is about 106% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in